Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 99

Biotechnology

New study expanded understanding of influenza-associated complications
Biotechnology | Diagnostics | Disease | Influenza | Therapeutics

New study expanded understanding of influenza-associated complications

On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…

Read More New study expanded understanding of influenza-associated complicationsContinue

Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
Biotechnology | COVID-19 | Therapeutics

Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease

On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…

Read More Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus diseaseContinue

Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients

On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…

Read More Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patientsContinue

University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
Biotechnology | COVID-19 | Disease | Medicine | Non-Profit Research | Therapeutics

University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue

On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…

Read More University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continueContinue

Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…

Read More Roche initiated phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumoniaContinue

UArizona Cancer Center received $69M grant forsSkin cancer prevention study
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

UArizona Cancer Center received $69M grant forsSkin cancer prevention study

On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…

Read More UArizona Cancer Center received $69M grant forsSkin cancer prevention studyContinue

FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
Biotechnology | FDA | Therapeutics

FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection

On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…

Read More FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infectionContinue

Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test
Biotechnology | COVID-19 | Diagnostics | Influenza | Medical Device

Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 test

On Mar. 19, 2020, Mesa Biotech announced it had been awarded a $561,000 contract from the U.S. Department…

Read More Mesa Biotech received funding from HHS for development of a 30 minute molecular point-of-care SARS-CoV-2 testContinue

Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research

Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virus

On Mar. 19, 2020, the Mayo Clinic announced it had significantly expanded its capacity to test clinical samples…

Read More Mayo Clinic Laboratories significantly expands testing capability for the COVID-19 virusContinue

Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide

On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…

Read More Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwideContinue

Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreement
Biotechnology | Diagnostics | Medical Device

Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreement

On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….

Read More Todos Medical signed novel Coronavirus (COVID-19) point-of-care rapid antibody testing kit exclusive distribution agreementContinue

Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs

On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…

Read More Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needsContinue

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…

Read More Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task ForceContinue

Oxford scientists developed rapid testing technology for COVID-19
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research

Oxford scientists developed rapid testing technology for COVID-19

On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…

Read More Oxford scientists developed rapid testing technology for COVID-19Continue

Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
Biotechnology | COVID-19 | FDA | Therapeutics

Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19

On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…

Read More Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19Continue

NIH researchers discovered tooth-enamel protein in eyes with dry AMD
Biotechnology | Medicine | NIH | Therapeutics

NIH researchers discovered tooth-enamel protein in eyes with dry AMD

On Mar. 17, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…

Read More NIH researchers discovered tooth-enamel protein in eyes with dry AMDContinue

CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in China

On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…

Read More CanSinoBIO’s investigational vaccine against COVID-19 approved for phase 1 clinical trial in ChinaContinue

Israel weighed “compassionate use” of Pluristem therapy for COVID-19
Biotechnology | COVID-19 | Therapeutics

Israel weighed “compassionate use” of Pluristem therapy for COVID-19

On Mar. 17, 2020, Israel’s Health Ministry announced that it had approved a request by Pluristem Therapeutics to…

Read More Israel weighed “compassionate use” of Pluristem therapy for COVID-19Continue

Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay
Biotechnology | COVID-19 | Diagnostics | FDA

Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assay

On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…

Read More Quidel received Emergency Use Authorization for molecular COVID-19 diagnostic assayContinue

MannKind refocuses pipeline resources in response to COVID-19 pandemic
Biotechnology | COVID-19

MannKind refocuses pipeline resources in response to COVID-19 pandemic

On Mar. 17, 2020, MannKind announced it is adjusting research and development resources that were reserved for its…

Read More MannKind refocuses pipeline resources in response to COVID-19 pandemicContinue

Regeneron announced important advances in novel COVID-19 antibody program
Biotechnology | COVID-19 | Therapeutics

Regeneron announced important advances in novel COVID-19 antibody program

On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…

Read More Regeneron announced important advances in novel COVID-19 antibody programContinue

Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
Biotechnology | COVID-19 | Diagnostics | FDA | Medical Device

Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed

On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…

Read More Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMedContinue

Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
Biotechnology | COVID-19 | Diagnostics | FDA

Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization

On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…

Read More Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use AuthorizationContinue

BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
Biotechnology | COVID-19 | Diagnostics | FDA

BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.

On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…

Read More BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.Continue

OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in Europe
Biotechnology | COVID-19 | Diagnostics

OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in Europe

On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…

Read More OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in EuropeContinue

Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
Biotechnology | COVID-19 | Therapeutics

Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19

On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…

Read More Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19Continue

UMN Institute scientist links ancient virus to cancer risk
Biotechnology | Medicine | Non-Profit Research

UMN Institute scientist links ancient virus to cancer risk

On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…

Read More UMN Institute scientist links ancient virus to cancer riskContinue

NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
Biotechnology | COVID-19 | Vaccine

NIH clinical trial of investigational vaccine for COVID-19 began in Seattle

On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…

Read More NIH clinical trial of investigational vaccine for COVID-19 began in SeattleContinue

Research on brain structure highlighted cells linked to Alzheimer’s and autism
Biotechnology | Disease | Neurology | Non-Profit Research

Research on brain structure highlighted cells linked to Alzheimer’s and autism

On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…

Read More Research on brain structure highlighted cells linked to Alzheimer’s and autismContinue

Aimmune announced first U.S. patients treated with PALFORZIA, the first treatment for peanut allergy
Biotechnology | FDA | Therapeutics

Aimmune announced first U.S. patients treated with PALFORZIA, the first treatment for peanut allergy

On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…

Read More Aimmune announced first U.S. patients treated with PALFORZIA, the first treatment for peanut allergyContinue

Page navigation

Previous PagePrevious 1 … 97 98 99 100 101 … 171 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search